Nat Commun July 2023 PMID 37407548

Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease.

Krithi Irmady, Caryn R Hale, Rizwana Qadri, John Fak, Sitsandziwe Simelane, Thomas Carroll, Serge Przedborski, Robert B Darnell

Mentions

15
Peak: 3 in Jul 2023
across 3 sources since Jul 2023

Extended reach

4,278
potential audience

Total likes

0

Video views

27

Mentions per month

Jul 2023 – Oct 2023

Where it's discussed

  • News10 articles
  • X / Twitter4 posts
  • YouTube1 videos

AI synopsis

What people are saying

Discussions highlight the promising potential of the blood-based biomarkers, with posts using terms like 'game-changing' and 'hope for early detection,' showing enthusiasm. However, some posts question the immediate clinical impact, reflecting a balanced tone that recognizes both significance and current limitations.

AgreementModerate agreement

Many discussions acknowledge the significance of linking blood markers to brain pathology in Parkinson's disease, reflecting moderate agreement with the study's findings.

InterestHigh interest

The topic of molecular signatures and potential for early diagnosis or treatment attracted high interest among commenters.

EngagementModerate engagement

While some users delve into implications and methodology, many simply express curiosity, indicating moderate engagement.

ImpactModerate impact

There is a sense that this research could influence future diagnostic approaches, but the overall perception is cautious and optimistic rather than revolutionary.

Abstract in brief

  • The study analyzed gene expression in the brains (caudate and putamen) of Parkinson's patients and controls, linking molecular changes to clinical symptoms like motor and cognitive issues.
  • They found that different molecular pathways are involved depending on whether Parkinson's onset occurs early or late, and that disease duration affects specific cell types in the brain.
  • Importantly, the gene patterns seen in the brain were also detectable in blood samples taken before death, suggesting blood tests could potentially predict disease progression and complications.

Top posts

Most liked on X and Bluesky
Krzysztof Potempa
@BRAINCURES · X

Jul 8, 2023 · 2,668 followers View post →
Researching the Brain
@Brain_Database · X

Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in #Parkinson’s disease #brain https://t.co/O6giw7x7p3

Aug 8, 2023 · 1,038 followers View post →
Ingentium Parkinson's Disease
@Ingentium_PD · X

Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease. https://t.co/WtaKQU9bVX https://t.co/iHxigSafo7

Jul 6, 2023 · 515 followers View post →
Parkinson's Disease Articles
@ParkinsonJC · X

Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease. https://t.co/KOpb85Xc02

Jul 6, 2023 · 30 followers View post →

All mentions

Researching the Brain
@Brain_Database · X

Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in #Parkinson’s disease #brain https://t.co/O6giw7x7p3

Aug 8, 2023 · 1,038 followers View post →
Krzysztof Potempa
@BRAINCURES · X

Jul 8, 2023 · 2,668 followers View post →
Ingentium Parkinson's Disease
@Ingentium_PD · X

Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease. https://t.co/WtaKQU9bVX https://t.co/iHxigSafo7

Jul 6, 2023 · 515 followers View post →
Parkinson's Disease Articles
@ParkinsonJC · X

Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease. https://t.co/KOpb85Xc02

Jul 6, 2023 · 30 followers View post →